INT56148

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.78
First Reported 1994
Last Reported 2009
Negated 0
Speculated 1
Reported most in Body
Documents 5
Total Number 7
Disease Relevance 1.87
Pain Relevance 0.93

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

endosome (PMEL) extracellular region (PMEL) Golgi apparatus (PMEL)
endoplasmic reticulum (PMEL) plasma membrane (PMEL)
Anatomy Link Frequency
T cells 2
blood 1
lymphocytes 1
PMEL (Homo sapiens)
Pain Link Frequency Relevance Heat
anesthesia 8 96.80 Very High Very High Very High
Opioid 5 91.44 High High
Inflammation 8 75.20 Quite High
cytokine 16 74.16 Quite High
abdominal pain 1 71.84 Quite High
alcohol 1 51.52 Quite High
cva 32 50.00 Quite Low
corticosteroid 3 5.00 Very Low Very Low Very Low
cINOD 3 5.00 Very Low Very Low Very Low
tolerance 3 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Hemorrhage 60 98.32 Very High Very High Very High
Stupor 1 95.80 Very High Very High Very High
Influenza Virus Infection 6 89.96 High High
Cancer 134 84.76 Quite High
Pancreatitis 10 84.56 Quite High
Alagille Syndrome 69 83.60 Quite High
Stress 1 78.24 Quite High
INFLAMMATION 8 75.20 Quite High
Abdominal Pain 1 71.84 Quite High
Congenital Anomalies 3 64.56 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
We found a significant enhancement of interferon-gamma (IFN-gamma) and soluble interleukin-2 receptor (sIL-2R) release in lipopolysaccharide (LPS)-stimulated whole blood cultures after induction of anesthesia.
Localization (release) of sIL in blood associated with anesthesia
1) Confidence 0.78 Published 2001 Journal J. Interferon Cytokine Res. Section Abstract Doc Link 11710990 Disease Relevance 0.25 Pain Relevance 0.74
When activated, lymphocytes secrete glycoproteins related to particular surface proteins, including soluble forms of the interleukin-2 receptor (sIL-2R) and of the surface proteins CD4 (sCD4) and CD8 (sCD8).
Localization (secrete) of sIL in lymphocytes
2) Confidence 0.73 Published 1994 Journal Digestion Section Abstract Doc Link 8063032 Disease Relevance 0.55 Pain Relevance 0.10
secreting CD8+ clones specific for gp100 and Melan A/MART-1 even before vaccination, and this high frequency did not change (gp100) or slightly decreased (Melan A/MART-1) after vaccination.
Localization (secreting) of gp100
3) Confidence 0.30 Published 2008 Journal J Transl Med Section Body Doc Link PMC2265680 Disease Relevance 0.20 Pain Relevance 0
For gp100, frequencies of 70 × 10-5 and 35 × 10-5 CD8+ T cells secreting IFN-?
Localization (secreting) of gp100 in T cells
4) Confidence 0.30 Published 2008 Journal J Transl Med Section Body Doc Link PMC2265680 Disease Relevance 0.22 Pain Relevance 0
i) For five patients enough PBMC were obtained before and 14 days after the fourth vaccination to analyze the presence of gp100 and Melan A/MART-1 specific CD8+T cells by tetramer staining.
Spec (analyze) Localization (presence) of gp100 in T cells
5) Confidence 0.28 Published 2008 Journal J Transl Med Section Body Doc Link PMC2265680 Disease Relevance 0.44 Pain Relevance 0
To avoid this, Ethics Committees in certain countries (Austria, Denmark and Germany) specified that consent must be obtained after surgery, in order to prove that surgeons' were not influenced in their decision to use TachoSil.
Localization (use) of TachoSil
6) Confidence 0.05 Published 2009 Journal Patient Saf Surg Section Body Doc Link PMC2711964 Disease Relevance 0 Pain Relevance 0
This prospective, non-interventional European surveillance study, conducted in a real-world clinical setting, suggests that patients undergoing surgery who receive TachoSil are not at increased risk of TEEs, major bleeding or immunological events.
Localization (receive) of TachoSil associated with hemorrhage
7) Confidence 0.05 Published 2009 Journal Patient Saf Surg Section Body Doc Link PMC2711964 Disease Relevance 0.22 Pain Relevance 0.09

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox